Schrodinger, Inc. financial data

Symbol
SDGR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1540 Broadway, 24 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 400 % -18.9%
Debt-to-equity 57 % +36.9%
Return On Equity -35.8 % -548%
Return On Assets -25.7 % -616%
Operating Margin -101 % -23.1%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 63M shares +1.31%
Entity Public Float 790M USD -55.1%
Weighted Average Number of Shares Outstanding, Basic 72.7M shares +1.25%
Weighted Average Number of Shares Outstanding, Diluted 72.7M shares -3.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 208M USD -4.21%
Cost of Revenue 75.5M USD -0.68%
Research and Development Expense 202M USD +11%
Selling and Marketing Expense 39.9M USD +7.23%
General and Administrative Expense 99.7M USD +0.53%
Operating Income (Loss) -209M USD -17.9%
Nonoperating Income (Expense) 23.6M USD -89.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -186M USD -533%
Income Tax Expense (Benefit) 1.41M USD -35.8%
Net Income (Loss) Attributable to Parent -187M USD -560%
Earnings Per Share, Basic -2.57 USD/shares -551%
Earnings Per Share, Diluted -2.57 USD/shares -576%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 147M USD -5.14%
Marketable Securities, Current 205M USD -33.4%
Accounts Receivable, after Allowance for Credit Loss, Current 236M USD +257%
Assets, Current 635M USD +11.8%
Property, Plant and Equipment, Net 22.5M USD +63.6%
Operating Lease, Right-of-Use Asset 112M USD -5.01%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 4.79M USD 0%
Other Assets, Noncurrent 4.16M USD -30.9%
Assets 823M USD +2.53%
Accounts Payable, Current 10.7M USD -36.6%
Contract with Customer, Liability, Current 112M USD +99.1%
Liabilities, Current 192M USD +43.4%
Contract with Customer, Liability, Noncurrent 109M USD +1103%
Operating Lease, Liability, Noncurrent 101M USD -8.95%
Other Liabilities, Noncurrent 146K USD -78.1%
Liabilities 402M USD +57.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 220K USD -21.7%
Retained Earnings (Accumulated Deficit) -526M USD -55.3%
Stockholders' Equity Attributable to Parent 421M USD -23.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 449M USD -20.3%
Liabilities and Equity 823M USD +2.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.3M USD -26.3%
Net Cash Provided by (Used in) Financing Activities 8.01M USD +823%
Net Cash Provided by (Used in) Investing Activities 5.08M USD -97.1%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 63M shares +1.31%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 163M USD +0.99%
Deferred Tax Assets, Valuation Allowance 177M USD +30.3%
Deferred Tax Assets, Gross 214M USD +13.5%
Operating Lease, Liability 121M USD +27.2%
Payments to Acquire Property, Plant, and Equipment 4.1M USD +14.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -187M USD -531%
Lessee, Operating Lease, Liability, to be Paid 189M USD +26.1%
Operating Lease, Liability, Current 16.8M USD -0.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.1M USD +42.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.9M USD +50.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68M USD +24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.8M USD +43.6%
Deferred Tax Assets, Operating Loss Carryforwards 51.5M USD +16.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.65M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.7M USD +38.7%
Operating Lease, Payments 7.53M USD +156%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.44M USD -18.4%
Deferred Tax Assets, Net of Valuation Allowance 37M USD -29.8%
Share-based Payment Arrangement, Expense 49.9M USD +4.31%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%